Turner Investments’s DexCom DXCM Stock Holding History

Turner Investments’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-62,000	Closed	-$1.36M	–	274
2016 Q3	$1.36M	Buy	62,000 +42,000	+210%	+$935K	0.45%	76
2016 Q2	$397K	Sell	20,000 -800	-4%	-$13.6K	0.12%	150
2016 Q1	$353K	Buy	20,800 +6,800	+49%	+$114K	0.1%	168
2015 Q4	$287K	Buy	14,000 +6,000	+75%	+$125K	0.06%	194
2015 Q3	$172K	Buy	+8,000	New	+$178K	0.03%	220
2014 Q4	–	Sell	-503,640	Closed	-$5.04M	–	503
2014 Q3	$5.04M	Buy	503,640 +177,240	+54%	+$1.81M	0.3%	105
2014 Q2	$3.24M	Buy	+326,400	New	+$2.89M	0.14%	198
2013 Q4	–	Sell	-416,816	Closed	-$2.94M	–	601
2013 Q3	$2.94M	Buy	+416,816	New	+$2.64M	0.05%	341

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Turner Investments's DXCM Position: Q4 2016 in Review

Turner Investments sold out of DexCom (DXCM) in Q4 2016, closing a stake of 62,000 shares — an estimated $1.36M sold.

Turner Investments first reported a position in DXCM in Q3 2013 and held it in 8 quarters. The position peaked at $5.04M in Q3 2014. 316 funds tracked by Wall St. Rank hold DXCM as of Q4 2016.

Turner Investments reported no remaining DexCom position as of Q4 2016 after selling out during the quarter.
Turner Investments sold 62,000 DexCom shares in Q4 2016, an estimated $1.36M.
Turner Investments first reported a position in DexCom in Q3 2013 and held it in 8 quarters.
Turner Investments's DexCom position peaked at $5.04M in Q3 2014.
316 funds tracked by Wall St. Rank held DexCom as of Q4 2016.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.